Home › Atherosclerosis › California › Santa Clarita
Atherosclerosis clinical trials in Santa Clarita, CA
3 studies for Atherosclerosis are looking for participants at sites in and around Santa Clarita (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
RecruitingPhase 3
- Valley Clinical Trials, Inc., Northridge · 11 mi away
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Renal Consultants Medical Group, Granada Hills · 9 mi away
- Amicis Research Center, Northridge · 11 mi away
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Northridge · 11 mi away
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Boston, MA10 studies
- Houston, TX10 studies
- Washington, DC9 studies
- Arlington, VA8 studies
- Orlando, FL8 studies
- Hialeah, FL8 studies
- Memphis, TN7 studies
- Miami, FL7 studies
- Las Vegas, NV7 studies
- Durham, NC7 studies
- Dallas, TX7 studies
- Los Angeles, CA6 studies
Other studies in Santa Clarita
- Obesity8 studies
- Heart Failure7 studies
- Atopic Dermatitis (Eczema)6 studies
- Type 2 Diabetes6 studies
- Overweight5 studies
- Cardiovascular Disease5 studies
- Asthma4 studies
- Hidradenitis Suppurativa4 studies
- Arrhythmia4 studies
- Bradycardia4 studies
- Chronic Kidney Disease4 studies
- Eczema4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.